Moonlake Immunotherapeutics - Class A (MLTX)'s 30-day implied volatility (IV30) was 83.8% at the close on November 12, 2026, up from 78.3% the day before, against a 52-week range of 48.8% to 195.7%. Its 20-day historical volatility was 74.6%.
Data as of November 12, 2026.